HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan Nicoll Selected Research

ABT 491

1/2020Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan Nicoll Research Topics

Disease

1Anaphylaxis (Anaphylactic Shock)
01/2020
1Shock
01/2020

Drug/Important Bio-Agent (IBA)

1salicylhydroxamic acid (SHAM)IBA
01/2020
1platelet activating factor receptorIBA
01/2020
1ABT 491IBA
01/2020
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2020